Forenap - smart solutions in CNS development
 
  • Linkedin
  • Twitter
  • Ajouter aux favoris
  • Imprimer
  • Envoyer par e-mail
 

A Full Service CRO

Forenap succeeds in any strategic and scientific challenge

Efficiency of a One Stop Shop from Discovery to Phase III

To develop a new drug, the choice of your partner is crucial. Time saving, tight budgets, expertise, rigor: your requirements correspond to the challenges faced from NCE characterization to market release of your drugs.
Consultancy, clinical research, operational and strategic partnerships, our services have only one goal: succeed, with you, in the challenges of a new drug development: Our Strength? We support you during the overall process:


The CNS expertise for your high specificity projects.

Neuroscience research has been our domain of expertise for the past 25 years.

We have performed hundreds of studies for which we have tested hundreds of centrally active new drugs. This experience positions Forenap as a worldwide leader in the early development of psychoactive drugs. Quantified EEG (qEEG) and ERPs, driving simulator, body sway, our state of the art technical platform, close to the lab, is available for very early evaluation of the activity of a molecule on the CNS. Our scientific knowledge of CNS is unique : it enables us to conduct atypical, specific and complicated projects. Our asset? Recommendation and support, in synergy with your team.

Forenap : a Partner at your side

The 120 Forenap employees and our 72 beds Clinical Pharmacology Unit (6000m²) specifically built to improve clinical trial performance, enable a great flexibility and solutions fitting with the highest pharmaceutical industry and health authorities standards. The development process of a new drug requires flexibility and reactivity. This is how we consider our relationship with you, because the success of your project is a common goal.

Chosing Forenap for its CNS expertise and high level technological platform is the best strategy to optimize your drug development

  • 25 years of experience in CNS
  • 120 employees
  • 9 of the top 10 big pharmaceutical companies already worked with us
  • 400 studies performed in 20 countries, from Japan to USA


They trust Forenap

“ Neurim has collaborated with Forenap for over 10 years. We have always found Forenap business, clinical and research team to be highly effective in that they has a keen understanding of specific trial needs and with remarkable capabilities and capacity in generating quality data."
Amnon Katz, PhD, Manager, Clinical Trials, Neurim Pharmaceuticals Ltd

" It has been a pleasure to work with Forenap, experienced professionals for various phase I clinical studies. Forenap is a customer focused CRO who demonstrates efficiency whilst not neglecting the quality of the studies."
Jutta Hänninen, Senior Clinical Study Manager, Orion Pharma

“ Forenap is an ideal partner for small pharma companies wanting to speed-up their entry in phase I. It is always a pleasure to work with Forenap experts in preclinical and pharmaceutical services.â€
Prof. Alexandre Vamvakides, Scientific Founder, Anavex Lifes Sciences Corp.